68 related articles for article (PubMed ID: 1963777)
41. Modification of calmodulin function by enzymatic carboxylic methylation.
Gagnon C; Kelly S; Manganiello V; Vaughan M; Odya C; Strittmatter W; Hoffman A; Hirata F
Nature; 1981 Jun; 291(5815):515-6. PubMed ID: 6262661
[No Abstract] [Full Text] [Related]
42. Purification and characterization of phosphodiesterase activator from kidney. A lysosomal protease.
Strewler GJ; Manganiello VC
J Biol Chem; 1979 Dec; 254(23):11891-8. PubMed ID: 227882
[No Abstract] [Full Text] [Related]
43. Presence of a MgATP/ADP-dependent pp50 phosphatase in bovine brain coated vesicles.
Pauloin A; Jollès P
J Biol Chem; 1986 Sep; 261(27):12568-73. PubMed ID: 2875074
[TBL] [Abstract][Full Text] [Related]
44. Kinetic model of biphasic action of psychotropic drugs on membrane-bound enzyme systems.
Datta C; Gupta MR
Indian J Exp Biol; 1977 Jan; 15(1):58-60. PubMed ID: 908593
[No Abstract] [Full Text] [Related]
45. [Kinetic properties and regulation of cyclic nucleotide phosphodiesterases in lymphoid cells].
Azhaeva EV; Severin ES
Bioorg Khim; 1987 Sep; 13(9):1157-63. PubMed ID: 2827690
[TBL] [Abstract][Full Text] [Related]
46. Cyclic nucleotide derivatives as probes of phosphodiesterase catalytic and regulatory sites.
Erneux C; Couchie D; Dumont JE; Jastorff B
Adv Cyclic Nucleotide Protein Phosphorylation Res; 1984; 16():107-18. PubMed ID: 6326517
[TBL] [Abstract][Full Text] [Related]
47. Inhibition and stimulation of photoreceptor phosphodiesterases by dipyridamole and M&B 22,948.
Gillespie PG; Beavo JA
Mol Pharmacol; 1989 Nov; 36(5):773-81. PubMed ID: 2555675
[TBL] [Abstract][Full Text] [Related]
48. [cGMP-dependent cyclic nucleotide phosphodiesterase from human lymphoid cells].
Azhaeva EV; Severin SE; Kondrat'ev AD
Biokhimiia; 1987 Nov; 52(11):1781-5. PubMed ID: 2830912
[TBL] [Abstract][Full Text] [Related]
49. A photoaffinity probe covalently modifies the catalytic site of the cGMP-binding cGMP-specific phosphodiesterase (PDE-5).
Corbin JD; Beasley A; Turko IV; Haik TL; Mangum KA; Wells JN; Francis SH; Sekhar KR
Cell Biochem Biophys; 1998; 29(1-2):145-57. PubMed ID: 9631243
[TBL] [Abstract][Full Text] [Related]
50. Equilibrium kinetics model for the cGMP-stimulated phosphodiesterase of brain coated vesicles.
Silva WI; Puszkin S
Bol Asoc Med P R; 1990 Sep; 82(9):407-11. PubMed ID: 1963777
[TBL] [Abstract][Full Text] [Related]
51. Cyclic GMP phosphodiesterases and regulation of smooth muscle function.
Rybalkin SD; Yan C; Bornfeldt KE; Beavo JA
Circ Res; 2003 Aug; 93(4):280-91. PubMed ID: 12933699
[TBL] [Abstract][Full Text] [Related]
52. Characterization of nitric oxide synthase, soluble guanylyl cyclase, and Ca2+/calmodulin-stimulated cGMP phosphodiesterase as components of neuronal signal transduction.
Mayer B; Koesling D; Böhme E
Adv Second Messenger Phosphoprotein Res; 1993; 28():111-9. PubMed ID: 7691122
[No Abstract] [Full Text] [Related]
53. Cyclic-GMP-regulated enzymes and their possible physiological functions.
Walter U
Adv Cyclic Nucleotide Protein Phosphorylation Res; 1984; 17():249-58. PubMed ID: 6145321
[No Abstract] [Full Text] [Related]
54.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
55.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
56.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
57.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
58.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
59.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
60.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
